Question 48

Hypertension should be noted in the patient's profile.

Benicar is primarily indicated for the treatment of hypertension, making it essential to note this disease state in the patient's profile to ensure proper management and monitoring of their condition.

A) Hypertension

This option is correct because Benicar (olmesartan) is an angiotensin receptor blocker specifically prescribed to lower blood pressure in patients with hypertension. Recognizing hypertension in the patient’s profile is critical for effective treatment and follow-up.

B) Diabetes

This option is incorrect as Benicar is not primarily used for managing diabetes. While some antihypertensive medications can have implications for diabetic patients, the direct connection to diabetes is not relevant for a prescription of Benicar.

C) Hypothyroid

This option is also incorrect. Benicar does not have a direct indication or therapeutic role in treating hypothyroidism. Therefore, noting hypothyroid status in the patient’s profile is not necessary in relation to this medication.

D) Hypercholesterolemia

This option is incorrect as well. Benicar does not address hypercholesterolemia, and it is not used to manage cholesterol levels. Including hypercholesterolemia in the patient’s profile would not provide relevant information for the prescription of Benicar.

Conclusion

In summary, noting hypertension in the patient's profile is vital as it directly relates to the use of Benicar for blood pressure management. The other options do not pertain to the primary use of this medication and therefore do not require attention in this context. Understanding the specific indications of medications is crucial for effective patient care.